Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PoorOpinionon Apr 13, 2018 11:03am
133 Views
Post# 27879376

RE:RE:Wo the engines.

RE:RE:Wo the engines.When should she do it? For the next 12 months she's going to be neck deep in sales data which Thera seems to want to only slowly release. That's going to look even worse from a moral, legal and company perspective. IMO now is the best time.

If people really are here for 1/2/3.years then they are going to have to learn to stop sweating ever small piece of company business.

Options are a nice bonus but they do represent salary paid as future success of the company rather than cash in hand today. She held these through the approval risk, if trogarzo didnt get approved those $2 options may have been worthless. She has the right to sell at the end of that process, just as she will have the right to sell in the future once the trogarzo market is established and known to all of us.

palinc2000 wrote: This is not about run of the mill exercising of options 
This is about exercising options at the worst possible time by the VP responsible for the launch  in a few hours of a game changing drug for the company,





Bullboard Posts